increase in TF-mediated, factor Vila-dependent factor Xa formation. Extracellular matrix derived from TNF-treated endothelium, prepared after removing the cells by hypotonic lysis or ammonium hydroxide (0.1 N), also had similarly enhanced TF activity. Incubation with a blocking monoclonal antibody t o TF inhibited the procoagulant activity of both TNF-stimulated endothelial cells, whether they were intact or permeabilized, and of their matrices. However, when the apical cell surface was pretreated with anti-TF antibody, HE PRINCIPAL ROLE of quiescent endothelium in T regulation of the hemostatic system is to promote blood fluidity by a combination of mechanisms, including inhibition of coagulation,' prevention of platelet deposition: removal of any fibrin that might form,3 and maintenance vessel tone! Stimulation of cultured endothelial cells with cytokines, such as tumor necrosis factor/cachectin (TNF), leads to a change in their coagulant properties through changes in cellular anticoagulant and procoagulant activities/cofactors. An important means through which TNF brings about these changes, at least in cell culture, involves induction of the synthesis of the procoagulant cofactor tissue factor (TF)?-6 Exposure of TF on the luminal endothelial surface would lead to rapid intravascular coagulation, which is rarely seen in vivo.
In view of the situation in vivo, where TF is localized in the subendotheIi~m,~-'~ we considered the possibility that endothelial TF is sequestered from factors VII/VIIa, IX, and X, the relevant enzyme and substrates with which it washed, and then cells were lysed with water or permeabilized with saponin, similar augmentation of TF activity was still observed, suggesting the presence of a pool of TF t o which the antibody did not initially gain access. Consistent with this concept, the presence of TF in the matrix of TNF-treated endothelial cells was shown by immunoblotting and morphologic studies; cultured endothelial monolayers and the native endothelium of aortic segments after exposure t o TNF showed TF in extracellular matrix, associated with vesicles. In contrast, TF was virtually undetectable on the apical endothelial surface. Taken together, these findings suggest that endothelial TF can be present in a cryptic pool that only gains access t o the blood after alteration in the integrity of the endothelial monolayer. 0 1992 by The American Society of Hematology.
interacts. Our results indicate that TNF-induced endothelial TF is not expressed on the apical surface but is in matrix-associated subendothelial vesicles. These results suggest an additional level of regulation for endothelial TF that limits exposure to plasma coagulation components until noxious stimuli disrupt the integrity of the cell monolayer.
MATERIALS AND METHODS
Endothelial cells derived from human umbilical cord veins were prepared by the method of Jaffe" as modified by Thomton et a1.'* Experiments were performed within 24 hours of the cells achieving confluence. Cultures were characterized by indirect immunofluorescence, based on the presence of von Willebrand factor antigen, thrombomodulin activity, and morphologic criteria.I3 Studies were performed using cultures (passage 2) that had obtained confluence within 4 to 7 days in 1.75 cm2 wells. To study induction of TF, the growth medium was aspirated and Medium 199 containing HEPES (10 mmol/L; pH 7.4), penicillin/streptomycin (50 U/mL and 50 pg/mL, respectively), and fetal calf serum (10%; Sterile Systems, Logan, UT) was added along with indicated concentration of purified recombinant TNF (=lox U/mg; generously provided by Dr P. Lomedico, Hoffmann-LaRoche, Nutley, NJ). After 6 to 8 hours of incubation at 37"C, TF activity was assessed as described below. Certain studies (see Morphologic Studies) also used bovine aortic endothelial cells, grown as previously d e s~r i b e d . '~J~ In studies with calf aortic segments, a 5 to 10 cm portion of the thoracic aorta was excised within minutes of killing the animal, placed in Hank's balanced salt solution containing 25 mg/mL bovine serum albumin, and transported to the laboratory at 21°C. The adventitia was removed, the segment was placed in a multiwell template containing growth medium (see above) without heparin or growth factor, warmed to 37°C and incubated with TNF for 6 hours. 16 Human factors X and Xa were purified to homogeneity as described." Monoclonal (IgG1 subclass) and rabbit polyclonal antibody to recombinant human TF was prepared and characterized as described previously,lX and the mouse monoclonal or rabbit polyclonal antibodies to bovine TF were prepared as d e s~r i b e d . '~~~~ The monospecificity of these antibodies for tissue factor is presented in each of the references. Monoclonal antibody to TF was radioiodinated using Enzymobeads (BioRad, Richmond, CA) following the manufacturer's Cell culture and aortic segments.
Coagulation proteins and antibodies. TF-mediated activation of factor X was studied after the incubation period of endothelial monolayers with TNF. Activation of factor X was examined on intact endothelial monolayers, monolayers briefly exposed to saponin (0.02% for 10 minutes at 22"C), and extracellular matrix prepared by treatment of the cell monolayer with either water or ammonium hydroxide (0.1 N), until cells were no longer visible, followed by extensive washing. In each case, binding buffer (0.5 mL) containing HEPES (10 mmol/L; pH 7.4), NaCl (137 mmol/L), KCI (4 mmol/L), glucose (11 mmol/L), CaC12 (2.5 mmol/L), and bovine serum albumin (0.5%) was added along with factor VIIa (1 nmol/L or the indicated concentration) and factor X (200 nmol/L). The mixture was incubated at 3 7 T , and one aliquot (50 pL) per well of the reaction mixture was withdrawn at 10, 15, 20, or 30 minutes (unless other times are indicated), and placed in 50 pL of HEPES (10 mmol/L; pH 7.4), NaCl (137 mmol/L), KCI (4 mmol/L), and glucose (11 mmol/L) containing EDTA (10 mmol/L) to stop the reaction. Factor Xa formation was assessed by monitoring the rate of hydrolysis of the chromogenic substrate Spectrozyme Xa (0.20 mmol/L; American Diagnostica, Greenwich, CT, generously provided by Dr Hart) at 22°C using a Vmax reader (Molecular Devices, Menlo Park, CA). The amount of factor Xa formed was determined from the linear portion of a standard curve made with known amounts of factor Xa (0 to 7.5 pmol). Where indicated, cultures were incubated with anti-TF IgG before the assay for activation of factor X was performed.
Binding of 1251-anti-TF IgG to endothelial monolayers was studied using 1.75 cm2 wells. After 6 to 8 hours of pretreatment of endothelial cells with TNF, cultures were washed and incubated with buffer containing nonimmune mouse IgG (10 pg/mL) and fetal calf serum (10%) alone or buffer supplemented with a blocking antihuman recombinant TF monoclonal antibody (6 pg/mL). The latter step, to block TF on the cell surface, was followed by washing to remove unbound antibody, permeabilization of the monolayer using saponin, or exposure of the matrix by hypotonic lysis of the cells. Then, endothelial-derived preparations were incubated with lZI-anti-TF monoclonal (60 ng/mL) alone (total binding) or in the presence of an 100-fold excess of unlabeled antibody (nonspecific).
Immunoblotting for tissue factor was performed on endothelial cell and matrix samples. Cell-lysates were prepared by treatment of monolayers with ammonium hydroxide. The remaining matrix was washed with phosphate-buffered saline (PBS), and TF-containing samples were prepared by scraping with a rubber policeman into PBS with Triton X-100 (0.1%). Samples were precipitated using trichloroacetic acid (TCA, 15%), washed twice with ice-cold acetone, and resolubilized in reduced SDS gel buffer.21 Samples were run on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (12.5% for lanes 1 to 2 and 7.5% for lanes 3 to 4 in Fig 6) , and transferred to nitrocellulose electrophoretically, using the dry blot system (Polyblot Transfer System; ABN, Emeryville, CA). The nitrocellulose was blocked with PBS-containing gelatin (3%) at 37°C overnight, and then reacted with rabbit polyclonal antibody to recombinant human TF (10 pg/mL) in buffer containing gelatin (1%) overnight at room temperature.** Bound antibody was detected after incubation with radioiodinated mouse antirabbit monoclonal antibody (2.5 pg/mL; Sigma).
For immunofluorescence, confluent endothelial monolayers were incubated in the presenceiabsence of TNF (10 nmol/L) for 5 hours at 37"C, and then the monolayers were Morphologic studies. fixed in 3.5% paraformaldehyde with/without 0.1% NP-40, and TF was localized using rabbit anti-TF IgG at 37°C for 60 minutes. Additionally, some monolayers were permeabilized using the same protocol as for the TF assay. For immunohistochemical localization of TF at the electron microscopic level, cells grown on Costar Transwell inserts (Cambridge, MA) were exposed to TNF as above, fixed in 3.5% paraformaldehyde, washed, incubated with primary antibody as above, and followed by peroxidase-conjugated secondary antibody (Sigma) at 37°C for 1 hour. After incubation in secondary antibody, cells were briefly fixed in 2% glutaraldehyde and the diaminobenzidine reaction was performed. After development of product, monolayers were postfixed in 2.5% glutaraldehyde, osmicated, and embedded for electron microscopy. Aortic segments, rapidly procured from animals after killing, were stripped of adventitia and mounted in a lucite template device allowing access to the luminal surface, as described previ~usly?~ The chamber divided the segment into two parts. One part was treated with TNF in growth medium (as above), and the other was incubated in normal culture medium alone. At the conclusion of the experiment, segments were washed in balanced salt solution, and fixed in 3.5% paraformaldehyde. A biopsy punch was used to remove tissue samples that were then transferred to fresh fixative for 18 hours at 4"C, and subsequently dehydrated and embedded in LR White resin (Polysciences, Warington, PA). Grids were stained for TF with the rabbit polyclonal antibody, and were shown with goat-antirabbit IgG conjugated to 12 nm gold particles (Sigma), and then stained with uranyl acetate and lead citrate for viewing in the electron microscope."
RESULTS
Quiescent endothelial monolayers had no detectable TF, based on factor VIIa-dependent factor X activation (Fig 1) . This was true whether cells were tested as intact monolay-I Quiescent TNF-treated I For personal use only. on November 15, 2017. by guest www.bloodjournal.org From ers, permeabilized with detergent, or removed by treatment with ammonium hydroxide. Only minor amounts of TF activity could be detected on intact cell monolayers 4 to 6 hours after addition of TNF. However, after permeabilization of the cultures by brief exposure to saponin, there was = 20-fold increase in tissue factor activity similar to increases seen in freeze/thaw preparations of scraped cells with matrix (data not shown). TF activity of saponin-treated cells was dependent both on the incubation time and dose of TNF (Fig 2A and B) . In each case, factor Xa formation was attributable to the presence of TF, as shown by its inhibition in the presence of anti-TF IgG (data not shown).
To begin to localize TF within the cell monolayer and underlying matrix, endothelial cells were removed with ammonium hydroxide to expose the matrix, by methods hitherto described.z,26 TF activity in matrix preparations appeared in a time-dependent manner after addition of TNF. The dependence of matrix-associated TF activity on TNF concentration roughly paralleled that observed with saponin-solubilized cells. Hypotonic lysis of TNF-treated endothelial monolayers, which also exposes the matrix, resulted in a similar increase in TF activity to that seen with ammonium hydroxide.
Several possible mechanisms could account for the increase in TF activity observed after ammonium hydroxide/ detergent-treatment of TNF stimulated endothelial cell cultures, including alterations in the arrangement of phospholipids with exposure of acidic lipids, removal of an inhibitor, or the presence of a cryptic pool. Recent studies in fibroblasts have shown that the calcium ionophore A23187 enhances TF activity.*' Exposure of TNF-treated endothelial cells to the calcium ionophore A23187 (at 10 and 20 kmol/L) showed only a threefold to fourfold enhancement of TF activity across a range of factor VIIa and X concentrations (data not shown). The major inhibitor of the TF pathway, TFPI, is an endothelial product that could mask TNF-induced TF acti~ity~~-~O; but preincubation of endothelial monolayers with neutralizing antibody to human TFPI showed only minor increases in TF activity compared with the matrix from the same cells (Fig 3) . When TNF-treated endothelial cultures were exposed simultaneously to both the anti-TFPI antibody and to the calcium ionophore, the combined effect of both agents was no more than a threefold to fourfold increase above the baseline observed in nonpermeabilized TNF-treated cultures.
To test whether enhanced TF activity after disruption of the TNF-treated endothelial monolayer was caused by TF apoprotein initially exposed on the cell surface, whose activity was modulated under our experimental conditions (such as detergent solubilization and/or hypotonic lysis resulting in phospholipid rearrangement), or whether additional, initially cryptic, TF was exposed by these treatments, intact, TNF-treated endothelial monolayers were preincu- For personal use only. on November 15, 2017. by guest www.bloodjournal.org From bated with anti-TF antibody to block cell surface antigen. Then, TF activity, as well as exposure of new TF antigen, was assessed after permeabilization or exposure of the matrix. Control experiments established that each of these treatments did not disrupt interaction of the antibody with TF. After blocking of TF on the surface of TNF-treated endothelial cells with anti-TF antibody, permeabilization with saponin resulted in enhanced levels of factor Xa formation, compared with controls not exposed to TNF (Fig 4A, I to IV) . Consistent with the view that the anti-TF IgG was not able to gain access to endothelial TF unless the cells had been permeabilized, addition of this antibody after saponin treatment blocked TF activity (Fig 4A, IV) . Similar results were observed in TNF-stimulated cultures exposed to hypotonic lysis. Hypotonic lysis enhanced TF activity even when TF on the apical surface of the cell had been previously blocked by addition of anti-TF IgG (Fig 4B, VI to X). When anti-TF antibody was incubated with cell preparations after lysis under hypotonic conditions, TF activity was blocked (Fig 4B, IX) . These data, suggesting that permeabilization of TNF-treated endothelial cells, as well as exposure of their matrix, provides access to the induced TF, were supported by the results of radioligand binding studies with anti-TF antibody. Specific binding of 1251-anti-TF IgG was enhanced on permeabilized, TNFtreated endothelial cultures, and on their matrices, compared with intact cells (data not shown).
The results of these coagulation physiology and antibody binding experiments led us to localize TF in the endothelial cell and underlying matrix after exposure of the cultures to TNF (Fig 5) . By (Fig 5A) or nonpermeabilized TNF-treated monolayers (Fig 5B) . In contrast, positive staining was evident when TNF-treated endothelial monolayers were first permeabilized; staining of vesicular structures was evident, as well as some diffuse staining, possibly representing intracellular TF and/or antigen associated with the basal surface of the cell (Fig 5C and D) . Extracellular localization of TF was confirmed by electron microscopy of nonpermeabilized cells (Fig 5E) , which showed TF antigen especially in the subendothelium associated with vesicle-like structures. Negligible amounts of T F were observed on the cell surface of TNF-treated endothelial cultures using the same ultrastructural techniques. Our morphologic and coagulation physiology studies suggested that TF was present in functional form in the extracellular matrix. As expected, immunoblots from endothelial cell lysates and matrix-derived from control cultures showed no bands with anti-TF antibody. In contrast, with lysates or matrix preparations derived from TNF-treated endothelial cultures, a major immunoreactive band was present corresponding to = 43 Kd (Fig 6) .
Enzymology studies were performed to determine parameters of factor VIIa-mediated activation of factor X by cultures permeabilized with saponin and matrix-preparations derived from TNF-treated endothelial cells (Fig 7) . Although it was difficult to accurately assess parameters of factor Xa formation on intact monolayer preparations, using the permeabilized cells and matrix from TNF-treated cultures, the half-maximal rate of factor Xa formation occurred at factor X and VIIa concentrations of 50 nmol/L and 0.05 nmol/L, respectively. Vmax was greatest on the saponin permeabilized cells, presumably because of the For personal use only. on November 15, 2017. by guest www.bloodjournal.org From contribution of both intracellular and matrix-associated TF. Matrix preparations from hypotonically lysed cells showed a lower Vmax, probably resulting from the removal of some intracellular TF.
Although T F expression by endothelial cells in culture has been shown with endotoxin and several inflammatory cytokines, including TNF and interleukin-l,S.6*-'l it has bcen more difficult to show endothelial T F in vivo.R To begin to bridge the gap between studies in cell culture and the in vivo setting, experiments were performed with the native endothelium of bovine aortic vessel segments. After incubation with TNF, immunoperoxidase studies found TF antigen in a pattcrn rcscmbling that observed in cultured endothelial cells (Fig 8A and B) , ie, the antigen was mostly localizcd to the endothelial cell layer and subendothelium. In the electron microscope, using gold conjugated anti-TF antibodies, T F was shown to be present predominately in subendothelial vesicle-like structures (Fig 8D) . This local- ization of TF was not seen in untreated control endothelial cultures (Fig 8C) , which also produced some matricial vesicles, but were devoid of demonstrable TF.
DISCUSSION
Previous studies have shown that exposure of cultured endothelial cells to the cytokine TNF leads to the synthesis and expression of TF, a cofactor considered to be the major initiator of coagulation in vivo.32 Exposure of T F on the vessel wall in vivo would be expected to correlate closely with activation of coagulation and fibrin formation on the vessel surface. However, fibrin formation localized to the luminal surface of an intact vessel is not a common occurrence, even in inflammatory lesions in which cytokines are present.-'-' In this context, after the intravenous infusion of large amounts of interleukin-1 into rabbits, very little TF activity was detectable on the surface of aortic segments, and only occasional fibrin in close association to surface was found. 34 It has been suggested that T F production by endothelium in vivo does not occur, or if it does, its expression is at levels difficult to detect.H.3sS36 However, evidence showing the presence of T F associated with the endothelium in inflamed placental vessels"' and in certain vascular beds after the infusion of endotoxids.36 led us to consider the alternative hypothesis that the activity of endothelial TF is tightly controlled.
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In this report, wc show that, in response to TNF, T F produced by cultured and by native endothelium in situ is not expressed to a significant extent on the luminal cell surface, based on morphologic and functional studies. Although our findings might at first appear to contradict previous reports, including our own, concerning the expression of TF by stimulated endothelial ~e l l s ,~'~~~ in the current experiments we have taken special precautions to insure the integrity of the monolayer before determining the TF. Cultures were not scraped or subjected to any treatment that might alter viability or detach the cell monolayer from the growth surface, such as EDTA-containing buffer or local anesthetics, before the T F determination. Furthermore, formation of thrombin and fibrin, both of which have been shown to alter integrity of the endothelial monodid not occur to an appreciable extent, because all studies were performed in thc presence of only purified factors VIIa and X. Under these conditions, TF antigen and activity was barely detectable on the surface of TNFstimulated cells.
Initially we considered it possible that an inhibitor such as TFP12X-3i1 might be inhibiting T F that was present on the cell surface, or that TF might not be optimally active because of its phospholipid milieu. However, when TNFtreated endothelial cultures were exposed to either neutralizing anti-TFPI antibody and/or the calcium ionophore A23187,27 a maximum increase of only threefold to fourfold in TF activity was observed. Rather, the potential procoagulant activity of TF was only realized after permeabilization of the cells with a low concentration of saponin, or removal of the cell monolayer, even when cell surface TF activity had been previously blocked by anti-TF antibody (the latter observation indicates that TF was not likely to have been on the cell surface at the start of the experiment). Immunolocalization studies showed TF antigen in cultured endothelial cells and aortic segments was associated with vesiclelike structures in the subendothelial matrix, but not on the apical cell surface to an appreciable extent. Furthermore, matrix-associated TF appeared to be intact, by Western blotting and in functional studies showing factor VIIamediated activation of factor X. Taken together, these data suggest that TF produced by endothelium in response to TNF is not expressed at a site that facilitates optimal interaction with its substrates and enzyme, but rather is sequestered in the matrix, within the cell and possibly on the basal surface. However, after disruption of the endothelium and/or exposure of the subendothelium, TF activity is expressed. These observations are in accordance with recent findings of Carson et a14' that activation of the complement cascade on the surface of fibroblasts, in which TF antigen is constituatively produced, leads to enhanced TF activity. In this context, earlier studies of Schorer et a14? showed that exposure of endotoxin-treated endothelial monolayers to hydrogen peroxide resulted in a large increase in TF activity in parallel with destruction of the monolayer.
The presence of TF in subendothelial matrix, and release of vesicles containing TF activity from cellular surfaces has been previously reported. Weiss et a17 observed TF activity on inverted vessel strips denuded of endothelium. A specialized situation is the observation of Almus et a143 that TF is present in Wharton's jelly of the umbilical cord, and can penetrate fenestrations of the muscularis media of the umbilical vein. Shedding of TF-rich vesicles has been observed from the surface of tumor cells, fibroblasts, and monocytes."-47 Our results on TNF-treated endothelial cells link these previous observations in the context of vessel wall biology by indicating that TF-containing vesicles can be released into the subendothelium. These TFcontaining vesicles are released only or chiefly at the basal cell surface and, in accordance with the previous report by Brox et a!$* we recovered only minimal TF activity from conditioned media, even after concentration by trapping on filters. This may represent an example of unidirectional 
